X-154312587-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_012253.4(TKTL1):āc.678G>Cā(p.Glu226Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000514 in 1,206,700 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 20 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000089 ( 0 hom., 0 hem., cov: 23)
Exomes š: 0.000056 ( 0 hom. 20 hem. )
Consequence
TKTL1
NM_012253.4 missense
NM_012253.4 missense
Scores
1
8
8
Clinical Significance
Conservation
PhyloP100: 0.350
Genes affected
TKTL1 (HGNC:11835): (transketolase like 1) The protein encoded by this gene is a transketolase that acts as a homodimer and catalyzes the conversion of sedoheptulose 7-phosphate and D-glyceraldehyde 3-phosphate to D-ribose 5-phosphate and D-xylulose 5-phosphate. This reaction links the pentose phosphate pathway with the glycolytic pathway. Variations in this gene may be the cause of Wernicke-Korsakoff syndrome. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Hemizygotes in GnomAdExome4 at 20 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TKTL1 | NM_012253.4 | c.678G>C | p.Glu226Asp | missense_variant | 6/13 | ENST00000369915.8 | NP_036385.3 | |
TKTL1 | NM_001145933.2 | c.660G>C | p.Glu220Asp | missense_variant | 6/13 | NP_001139405.1 | ||
TKTL1 | NM_001145934.2 | c.510G>C | p.Glu170Asp | missense_variant | 5/12 | NP_001139406.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TKTL1 | ENST00000369915.8 | c.678G>C | p.Glu226Asp | missense_variant | 6/13 | 1 | NM_012253.4 | ENSP00000358931.3 |
Frequencies
GnomAD3 genomes AF: 0.00000893 AC: 1AN: 111966Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34132
GnomAD3 genomes
AF:
AC:
1
AN:
111966
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34132
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000223 AC: 4AN: 179035Hom.: 0 AF XY: 0.0000157 AC XY: 1AN XY: 63685
GnomAD3 exomes
AF:
AC:
4
AN:
179035
Hom.:
AF XY:
AC XY:
1
AN XY:
63685
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000557 AC: 61AN: 1094734Hom.: 0 Cov.: 30 AF XY: 0.0000555 AC XY: 20AN XY: 360358
GnomAD4 exome
AF:
AC:
61
AN:
1094734
Hom.:
Cov.:
30
AF XY:
AC XY:
20
AN XY:
360358
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000893 AC: 1AN: 111966Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34132
GnomAD4 genome
AF:
AC:
1
AN:
111966
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34132
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
0
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
5
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 16, 2024 | The c.678G>C (p.E226D) alteration is located in exon 6 (coding exon 6) of the TKTL1 gene. This alteration results from a G to C substitution at nucleotide position 678, causing the glutamic acid (E) at amino acid position 226 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
H;.
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
P;.
Vest4
MutPred
Gain of relative solvent accessibility (P = 0.0479);.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at